It's Boston local news in one concise, fun and informative emailThank you! You have been subscribed to WBUR Today.We were unable to subscribe you to WBUR Today. You can try subscribing here or try again later.
In 2015, the Sandoz unit of drugmaker Novartis won Food and Drug Administration approval of a drug called Zarxio, which is similar to Amgen's Neupogen, a medicine that boosts the production of white blood cells. (Sebastien Bozon/AFP/Getty Images)
